Trina Poretta
Experienced in Anemia

Dr. Trina Poretta

Oncology
Jefferson Health
705 White Horse Road, Suite D105, 
Voorhees, NJ 
Clinical Trials:Currently Recruiting for 1 Trial

Experienced in Anemia
Jefferson Health
705 White Horse Road, Suite D105, 
Voorhees, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Trina Poretta is an Oncologist in Voorhees, New Jersey. Dr. Poretta is rated as an Experienced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Paget Disease of the Breast.

Her clinical research consists of co-authoring 7 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Rowan University School Of Osteopathic Medicine
Residency
Rowan University School of Osteopathic Medicine
Specialties
Oncology
Licenses
Specialist in NJ
Board Certifications
Oncology
Hematology
Fellowships
Cooper University Health Care
Hospital Affiliations
Jefferson Washington Township Hospital
Jefferson Cherry Hill Hospital
Jefferson Stratford Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

705 White Horse Road, Suite D105, Voorhees, NJ 08043

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: a Phase III Study
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: a Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: January 10, 2025
Intervention Type: Drug
Study Drugs: Fulvestrant, Anastrozole
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
View 5 Less Clinical Trials

7 Total Publications

Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators.
Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators.
Journal: Anticancer research
Published: December 19, 2022
View All 7 Publications
Similar Doctors
Distinguished in Anemia
Dr. Stella Chou
Hematology | Oncology
Distinguished in Anemia
Dr. Stella Chou
Hematology | Oncology

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (13.0 miles away)
215-590-3535
Languages Spoken:
English
See accepted insurances

Stella Chou is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Chou is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Acute Megakaryoblastic Leukemia, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.

Distinguished in Anemia
Dr. John D. Sprandio
Oncology | Hematology
Distinguished in Anemia
Dr. John D. Sprandio
Oncology | Hematology

Consultants In Medical Oncology And Hematology PC

500 Evergreen Dr, Suite G4, 
Glen Mills, PA 
 (28.9 miles away)
610-887-0303
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Sprandio is an Oncologist and a Hematologist in Glen Mills, Pennsylvania. Dr. Sprandio is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Familial Colorectal Cancer, Anemia, Colorectal Cancer, and Venous Thromboembolism (VTE).

Distinguished in Anemia
Dr. Sandra F. Schnall
Hematology Oncology | Hematology | Oncology
Distinguished in Anemia
Dr. Sandra F. Schnall
Hematology Oncology | Hematology | Oncology
825 Old Lancaster Rd, Suite 320, 
Bryn Mawr, PA 
 (21.3 miles away)
610-527-3800
Languages Spoken:
English
See accepted insurances

Sandra Schnall is a Hematologist Oncology specialist and a Hematologist in Bryn Mawr, Pennsylvania. Dr. Schnall is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration.

VIEW MORE ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Poretta's expertise for a condition
ConditionClose
      • Advanced
      • Adult Immune Thrombocytopenia
        Dr. Poretta is
        Advanced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Angiosarcoma
        Dr. Poretta is
        Advanced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      • Breast Cancer
        Dr. Poretta is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Hemangioma Thrombocytopenia Syndrome
        Dr. Poretta is
        Advanced
        . Learn about Hemangioma Thrombocytopenia Syndrome.
        See more Hemangioma Thrombocytopenia Syndrome experts
      • Immune Thrombocytopenic Purpura (ITP)
        Dr. Poretta is
        Advanced
        . Learn about Immune Thrombocytopenic Purpura (ITP).
        See more Immune Thrombocytopenic Purpura (ITP) experts
      • Inflammatory Breast Cancer
        Dr. Poretta is
        Advanced
        . Learn about Inflammatory Breast Cancer.
        See more Inflammatory Breast Cancer experts
      View All 15 Advanced Conditions
      • Experienced
      • Acute Hepatic Porphyria (AHP)
        Dr. Poretta is
        Experienced
        . Learn about Acute Hepatic Porphyria (AHP).
        See more Acute Hepatic Porphyria (AHP) experts
      • Acute Intermittent Porphyria
        Dr. Poretta is
        Experienced
        . Learn about Acute Intermittent Porphyria.
        See more Acute Intermittent Porphyria experts
      • Adult Soft Tissue Sarcoma
        Dr. Poretta is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Agranulocytosis
        Dr. Poretta is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Poretta is
        Experienced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Anal Cancer
        Dr. Poretta is
        Experienced
        . Learn about Anal Cancer.
        See more Anal Cancer experts
      View All 56 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.